MedTrace Logo

Intraoperative Lidocaine Infusion

NCT07150481 · Status: NOT_YET_RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-09-02

No results posted yet for this study

Summary

This study aims to evaluate the analgesic and anti-inflammatory effect of perioperative intravenous lidocaine infusion and in turn the return of gastric motility in patients undergoing elective laparoscopic cholecystectomy.

Conditions

  • Enhanced Recovery After Anesthesia

Interventions

DRUG

IV Lidocaine infusion

2 mg/kg/h (the total dose of lidocaine per hour will be calculated and add to normal saline 0.9% to total volume 50 ml and infused by a rate 50 ml/h till the end of the procedure

DRUG

IV normal saline

IV normal saline 0.9% , rate 50 ml/h

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Noha Y Mohamed, MD · Lecturer in anesthesia and intensive care department, faculty of medicine,

  • Noha Y Mohammed, MD · Lecturer in anesthesia and intensive care department, faculty of medicine,

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-31
Primary Completion
2026-12-31
Completion
2027-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07150481 on ClinicalTrials.gov